# Tiger Jade Capital > Tiger Jade Capital is a VC fund in Central and Western backing Biotechnology and Oncology. See 3 investments, check sizes, portfolio. Updated Aug 2026. - Type: VC Fund - Location: Central and Western, Hong Kong - Total investments: 3 - Last investment: Jun 2026 - Lead investor: 67% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/company/tiger-jade-capital/ - Website: http://www.tigerjadecapital.com/ Tiger Jade Capital is a VC fund in Central and Western focused on Biotechnology and Oncology. Tiger Jade Capital is the support and cornerstone investment of China's leading CRO Company TigerMed. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Biotechnology | 2 | 67% | | Oncology | 1 | 33% | | Biopharma | 1 | 33% | | Health Care | 1 | 33% | | Life Science | 1 | 33% | 6 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Series A | 1 | 33% | | Series B | 1 | 33% | | Venture - Series Unknown | 1 | 33% | ### Country | Country | Investments | Share | | --- | --- | --- | | Hong Kong | 1 | 33% | | United States | 1 | 33% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Spot Biosystems | Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's headquarters are in Palo Alto, California. | $40M | Venture - Series Unknown | Jun 17, 2026 | | | Great Bay Bio | Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages. | $15M | Series A | Sep 13, 2022 | | | Great Bay Bio | Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages. | $15M | Series B | Sep 13, 2022 | | 3 of 3 investments shown. ## Co-investors - [AEF Greater Bay Area Fund](https://shizune.co/investors/profile/aef-greater-bay-area-fund) — VC Fund, 2 deals together - [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund, 2 deals together - [Alon Capital Ltd](https://shizune.co/investors/profile/alon-capital-partners) — VC Fund, 2 deals together - [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund, 2 deals together - [Vectr](https://shizune.co/investors/profile/vectr) — VC Fund, 2 deals together - [Advantech Capital](https://shizune.co/investors/profile/advantech-capital) — VC Fund, 1 deal together ## Similar investors ### Similar industry - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund - [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund ### Similar country - [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund - [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund - [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund ## Featured in investor lists - [Biotechnology Investors in Hong Kong](https://shizune.co/investors/biotechnology-investors-hong-kong) - [Biotechnology VC Funds in Hong Kong](https://shizune.co/investors/biotechnology-vc-funds-hong-kong) - [Health Care VC Funds in Hong Kong](https://shizune.co/investors/health-care-vc-funds-hong-kong) - [Biotech VC Funds in Hong Kong](https://shizune.co/investors/biotech-vc-funds-hong-kong) - [Life Science Investors in Hong Kong](https://shizune.co/investors/life-science-investors-hong-kong) - [Life Science VC Funds in Hong Kong](https://shizune.co/investors/life-science-vc-funds-hong-kong) ## FAQ ### What does Tiger Jade Capital invest in? Tiger Jade Capital invests primarily in Biotechnology, Oncology and Biopharma startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Tiger Jade Capital last invest? The most recent investment recorded for Tiger Jade Capital closed in Jun 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co